The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

Author： Kalliolias George D   C Liossis Stamatis-Nick  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.3, 2008-03, pp. : 349-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tocilizumab reduces disease activity in patients with systemic-onset juvenile idiopathic rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Rheumatoid arthritis costly at onset

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome

By Zhang Wen-Ming   Xu Ling-Yun   Lu Yan-ming   Cao Lan-Fang  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 176-181

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)

By Agle Lucila MA   Rosenkranz Margalit   Lehman Thomas JA  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Sulfasalazine: Haemophagocytic syndrome in a patient with adult-onset Still's disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1312, 2010-01 ,pp. : 41-42

Adis International

Access to resources Recommend Favorite